Nassif David W.
- SEC CIK
- 0001636975
In the past year, 2 open-market sale filings worth $521.9K and no purchases.
Current role at each company
- PHVS Pharvaris N.V.CFO / CLOas of Sep 23, 2026
- SIOX Sio Gene Therapies Inc.Interim CEO, CFOas of Feb 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $521.9K
- 2 filings
- Net
- −$521.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Nassif David W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PHVS Pharvaris N.V.
CFO / CLO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)10:06 AM ET | Sep 21 | 2 days | Nassif David W.CFO / CLO | SSale | −6.00K | $36.47 | −$218.8K | −5.0%114.3K after | |
| May 26, 2026 (view filing) | May 21 | 5 days | Nassif David W.CFO / CLO | SSale | −10.0K | $30.31 | −$303.1K | −7.7%120.3K after |